Event Guide

Your financial prep guide for the Medical Spa Show 2027

AmSpa's Medical Spa Show returns to the Wynn Las Vegas April 15-18, 2027, the event built around the business, legal, and financial side of running a med spa rather than the clinical one. Ownership structure, compliance, and profitability are the agenda, which makes it the most directly relevant aesthetics conference for an owner watching the P&L. Sorso is not an exhibitor, sponsor, or speaker at this event. This is an independent prep guide for med spa owners and operators.

Apr 15-18, 2027Wynn Las Vegas, NVMed spa owners and operatorsOfficial website →

The CFO read

Most aesthetics conferences sell equipment or growth tactics. AmSpa's show is the one built around the parts of a med spa that decide whether it is legal and whether it makes money: how you are structured, how you stay compliant, and where the margin actually comes from. For an owner, that is the more valuable trip, because a structural or compliance mistake costs more than any device on a show floor. Before Las Vegas, get clear on two things: whether your ownership and medical director structure holds up in your state, and which of your services actually carry the practice. The sessions land harder when you already know your own numbers.

— Stanislav Sukhinin, CFA · Founder, Sorso

Why this matters for your bottom line

AmSpa's event is organized around the questions that decide whether a med spa is compliant and profitable: who can legally own it, how the medical director relationship is structured, and how the entity is set up. Those decisions sit upstream of every financial result.

Ownership and management structures in aesthetics vary by state and carry real tax and liability consequences. A structure that was fine at one location can become a problem as you add sites or partners.

Med spa profitability is a service-mix question. The treatments that fill the schedule are not always the ones that carry the margin, and owners who track profit per service make different decisions than owners who track revenue.

Injectable and device pricing pressure keeps rising as competition grows. Knowing your cost per treatment and your provider productivity is what lets you hold margin without chasing competitors down on price.

What to look for

01

Sessions on ownership and management structure, including MSO models and medical director agreements, with the state-specific compliance rules

02

Compliance content that carries direct financial consequences: good-standing requirements, scope of practice, and supervision rules

03

Profitability sessions that break down margin by service line rather than total revenue

04

Membership and package pricing models, evaluated on patient lifetime value and retention

05

Provider compensation and productivity structures that align pay with the margin each provider generates

Financial prep checklist

Review these before you go.

Map profit margin by treatment type, including product cost, room time, and provider time, not just the price

Confirm your ownership and medical director structure against your state's current requirements before you invest in growth

Run provider productivity: revenue and margin per provider hour for each injector and aesthetician

Estimate patient acquisition cost by channel and lifetime value by service line

Review membership and package economics: retention rate and the margin each plan actually contributes

Inventory device and injectable costs and calculate the break-even volume for each major line

Stanislav Sukhinin, CFA — Founder of Sorso
Stanislav Sukhinin, CFA

Founder of Sorso and a CFA charterholder. Before Sorso, Stan spent 19 years in corporate finance at institutions including UniCredit and Société Générale — managing a $450M loan portfolio and making senior partner at a major mezzanine lender by 29 — then built a fractional CFO firm exclusively for outpatient healthcare clinics.